Drugs / Yttrium [90Y] Microsphere Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07334483 | Aug 2025 → Dec 2027 expected | hepatocellular carcinoma | GrandPharma (China) Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yttrium [90Y] Microsphere Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07334483 ↗ |